144 related articles for article (PubMed ID: 937167)
41. Allopurinol in primary gout with and after the administration of uricosuric agents.
Kersley GD
Ann Rheum Dis; 1966 Nov; 25(6 Suppl):643-4. PubMed ID: 5958694
[No Abstract] [Full Text] [Related]
42. Pharmacology of uricosuric drugs.
Kippen I; Whitehouse MW; Klinenberg JR
Ann Rheum Dis; 1974 Jul; 33(4):391-6. PubMed ID: 4213293
[No Abstract] [Full Text] [Related]
43. Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients.
Hanvivadhanakul P; Akkasilpa S; Deesomchok U
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S40-7. PubMed ID: 12188443
[TBL] [Abstract][Full Text] [Related]
44. Clinical trials of uric acid lowering for coronary heart disease risk reduction.
Simon JA
Am J Med; 2006 Apr; 119(4):e5; author reply e7. PubMed ID: 16564763
[No Abstract] [Full Text] [Related]
45. [Treatment of the gouty diathesis with a xanthine oxidase inhibitor. A clinical trial of allopurinol].
Nyfos L
Ugeskr Laeger; 1967 Feb; 129(8):253-7. PubMed ID: 5599222
[No Abstract] [Full Text] [Related]
46. [Management of hyperuricemia in diabetes].
Hirai A; Saito Y
Nihon Rinsho; 1997 Nov; 55 Suppl():781-5. PubMed ID: 9434564
[No Abstract] [Full Text] [Related]
47. [How to treat gout].
Sans Solá L
Rev Esp Reum Enferm Osteoartic; 1966 Jul; 11(7):497-523. PubMed ID: 4297957
[No Abstract] [Full Text] [Related]
48. [Early diagnosis and early treatment of gout].
Mertz DP
Hippokrates; 1968 Jan; 39(1):5-12. PubMed ID: 5667616
[No Abstract] [Full Text] [Related]
49. [Use of sorption for the correction of hyperuricemia in the combined treatment of gout].
Matulis AA; Bareĭkene IP; Venalis AI
Ter Arkh; 1987; 59(12):17-9. PubMed ID: 3447284
[No Abstract] [Full Text] [Related]
50. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.
Halpern R; Mody RR; Fuldeore MJ; Patel PA; Mikuls TR
Curr Med Res Opin; 2009 Jul; 25(7):1711-9. PubMed ID: 19485724
[TBL] [Abstract][Full Text] [Related]
51. Therapy of gout.
Gaines LM
Johns Hopkins Med J; 1967 Nov; 121(5):361-4. PubMed ID: 6075623
[No Abstract] [Full Text] [Related]
52. Hyperuricemia in neoplastic disease in children: prevention with allopurinol, a xanthine oxidase inhibitor.
Krakoff IH; Murphy ML
Pediatrics; 1968 Jan; 41(1):52-6. PubMed ID: 5635486
[No Abstract] [Full Text] [Related]
53. [A new uricemia-lowering agent: benziodarone. Its use in therapy of urate retention in the course of chronic renal insufficiency].
Bossini A; De Martino Rosaroll G
Policlinico Prat; 1969 Jul; 76(30):961-73. PubMed ID: 5402682
[No Abstract] [Full Text] [Related]
54. [Allopurinol in the treatment of hyperuricemia and chronic gout].
Benedetti A; Nardini A; Busonera G
Clin Ter; 1968 Apr; 45(2):141-54. PubMed ID: 5736585
[No Abstract] [Full Text] [Related]
55. A short trial assessment of uricosuric therapy in gout.
Palmer DG; Highton TC
Australas Ann Med; 1968 Aug; 17(3):242-7. PubMed ID: 5684610
[No Abstract] [Full Text] [Related]
56. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP; Leung KT; Tong MK; Kwan TH
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[TBL] [Abstract][Full Text] [Related]
57. Effect of some uricosuric and anti-inflammatory drugs on the binding of uric acid to human serum albumin in vitro.
Bluestone R; Kippen I; Klinenberg JR; Whitehouse MW
J Lab Clin Med; 1970 Jul; 76(1):85-91. PubMed ID: 5425366
[No Abstract] [Full Text] [Related]
58. [Pharmacological studies of diuretics. 4. Changes of serum uric acid level by the succesive administration of thiazide diuretics and other drugs and effects of uricosuric drugs].
Suzuki Y; Ina K; Ito M; Yamagami I
Nihon Yakurigaku Zasshi; 1971 Jan; 67(1):89-99. PubMed ID: 5102087
[No Abstract] [Full Text] [Related]
59. [Therapeutic agents for gout effecting the kidney].
Ueda Y; Kono H; Kobayashi Y; Kagawa K; Yonezawa H
Geka Chiryo; 1970 Mar; 22(3):317-22. PubMed ID: 5467650
[No Abstract] [Full Text] [Related]
60. Effects of cassia oil on serum and hepatic uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver.
Zhao X; Zhu JX; Mo SF; Pan Y; Kong LD
J Ethnopharmacol; 2006 Feb; 103(3):357-65. PubMed ID: 16182482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
